Exela Technologies, Inc. (XELA) – Breach of Fiduciary Duties Investigation

Have You Held Exela Stock Since September 2017? Exela Technologies Investors May Have Legal Claims Against The Company’s Officers and Directors.

Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Exela Technologies, Inc. (“Exela”) (NASDAQCM: XELA) breached their fiduciary duties to Exela and its shareholders.

In a March 17, 2020 “Notification of Late Filing,” Exela disclosed that it was unable to file its Form 10-K for the year-ended December 31, 2019 on time and would need to restate certain of its financial statements.

In a Form 8-K, dated March 17, 2020, Exela disclosed that Exela would need to restate its financial statements for 2017, 2018, and interim periods through September 30, 2019, as a result of a material weakness in its internal control over financial reporting.

Subsequently, in a May 21, 2020 SEC filing, Exela announced the resignation of its CFO.

Investors Who Have Held Exela Stock Shares Since September 2017 May Have Legal Claims

If you have held Exela stock since September 2017, please contact Kehoe Law Firm, P.C., John Kehoe, Esq., (215) 792-6676, Ext. 801, [email protected], [email protected], for a free, confidential consultation and no-obligation evaluation of potential legal claims.

Peloton (NASDAQ: PTON) Breach of Fiduciary Duties Investigation

Have You Held Peloton Stock Since At Least October 2020? Peloton Interactive, Inc. Investors May Have Legal Claims Against The Company’s Officers and Directors.

Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Peloton Interactive, Inc. (“Peloton”) (NASDAQ: PTON) breached their fiduciary duties to Peloton and its shareholders. 

The investigation concerns whether members of Peloton’s board of directors or senior management failed to manage Peloton in an acceptable manner, in breach of their fiduciary duties to Peloton, and whether Peloton and its shareholders have suffered damages as a result.

As recently reported by various news outlets and confirmed by filings with the Securities and Exchange Commission, Peloton’s founders, directors, and officers collectively sold nearly $500 million in stock before disclosing recent production stoppages, sales declines, and employee layoffs, which have caused dramatic declines in Peloton’s stock price.

Peloton Investors Who Have Held PTON Stock Shares Since At Least October 2020

If you are a Peloton shareholder who has held Peloton stock since at least October 2020, please contact Kehoe Law Firm, P.C., Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected][email protected], for a free, confidential consultation and no-obligation evaluation of potential legal claims.

Roblox (NYSE: RBLX) Breach of Fiduciary Duties Investigation

Have you held Roblox Stock Since March 2021? Roblox Corporation Investors May Have Legal Claims Against The Company’s Officers and Directors.

Kehoe Law Firm, P.C. is investigating whether certain directors and officers of Roblox Corporation (“Roblox”) (NYSE: RBLX) breached their fiduciary duties to Roblox and its shareholders.

The investigation concerns whether members of Roblox’s board of directors or senior management failed to manage Roblox in an acceptable manner, in breach of their fiduciary duties to Roblox, and whether Roblox and its shareholders suffered damages as a result.

On February 3, 2022, The Bear Cave published a report alleging that Roblox’s online platform intended for children aged six to fourteen is “also the leading platform for pedophiles.” The report detailed various arrests and indictments of sexual offenses against underage victims as young as five years old, while “[t]he company has engaged in litigation and intimidation to help conceal allegations of pedophilia on the platform.”

Further, Roblox’s head of safety and moderation has been accused of “peculiar” social media activity, including numerous “likes” of sexualized cosplayers and the following of a “furry porn” account, and Roblox’s former social media manager allegedly ran a pornographic blog while employed by Roblox.

Roblox Investors Who Have Held RBLX Stock Shares Since March 2021

If you are a Roblox shareholder who has held Roblox stock since March 2021, please contact Kehoe Law Firm, P.C., Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], for a free, confidential consultation and no-obligation evaluation of potential legal claims.

LM ERICSSON TELEPHONE CO (Telefonaktiebolaget LM Ericsson)

LM Ericsson Telephone Co (Telefonaktiebolaget LM Ericsson) – Investors of Ericsson (NASDAQ: ERIC) Who Have Suffered Financial Losses Encouraged To Contact Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is investigating whether Telefonaktiebolaget LM Ericsson (“Ericsson”) (NASDAQ: ERIC) violated federal securities laws.

On February 16, 2022, The Telegraph reported that “Ericsson has admitted that it may have bribed the terrorist group Islamic State in return for being allowed to use roads through Iraq.”

On this news, shares of Ericsson were down more than 14% in pre-market trading on February 16, 2022.

Ericsson Provides Update on Deferred Prosecution Agreement

On March 2, 2022, Ericsson reported that “[o]n December 6, 2019, Ericsson entered into a Deferred Prosecution Agreement (DPA) with the United States Department of Justice (DOJ). On March 1, 2022, the DOJ informed Ericsson that the disclosure made by the company prior to the DPA about its internal investigation into conduct in Iraq in the period 2011 until 2019 was insufficient. Furthermore, it determined that the company breached the DPA by failing to make subsequent disclosure related to the investigation post-DPA. The company is in communication with the DOJ regarding the facts and circumstances of the breach determination and is committed to co-operating with the DOJ to resolve the matter.” (Emphasis added.)

ERICSSON INVESTORS WHO HAVE SUFFERED FINANCIAL LOSSES ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM’S SECURITIES CLASS ACTION QUESTIONNAIRE.
ERICSSON INVESTORS ARE ALSO ENCOURAGED TO CONTACT JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], [email protected], TO DISCUSS THE ERICSSON SECURITIES CLASS ACTION INVESTIGATION AND POTENTIAL LEGAL CLAIMS.

Clariant AG – OTC: CLZNY

Clariant AG Investor Alert – Investors Of Clariant AG’s Securities Who Have Suffered Financial Losses Encouraged To Contact Kehoe Law Firm, P.C. 

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Clariant AG (“Clariant” or the “Company”) (OTC: CLZNY).

On February 14, 2022, Reuters reported that “Clariant has delayed the release of its 2021 results as investigators probe whistleblowers’ allegations that some staff manipulated accounts in 2020 and 2021 to help meet financial targets, the Swiss specialty chemicals group said on Monday.”

On this news, shares of Clariant dropped significantly during intraday trading on February 14, 2022. 

Clariant Investors Who Have Suffered Financial Losses

Investors of Clariant securities who have suffered financial losses are encouraged to complete Kehoe Law Firm’s Securities Class Action Questionnaire or contact Kehoe Law Firm, P.C., [email protected], to discuss potential legal claims. 

Cortexyme, Inc. – NASDAQ: CRTX

Cortexyme, Inc. Investor Alert – Cortexyme Shareholders Who Have Suffered Losses On Their CRTX Investment Encouraged To Contact Kehoe Law Firm, P.C. 

On January 26, 2022, Cortexyme, Inc. (“Cortexyme” or the “Company”) (NASDAQ: CRTX) announced that it received a letter from the U.S. Food and Drug Administration (“FDA”) on January 25, 2022, placing a full clinical hold on atuzaginstat’s (COR388) Investigational New Drug application (IND 134303). The Company also announced the immediate implementation of a cost reduction program to rationalize operations.

On this news, shares of Cortexyme dropped more than 30%, closing at $6.21 per share on January 26, 2022. 

Cortexyme also reported that on February 2, 2022, the Company’s Board of Directors approved the previously announced cost reduction program  to rationalize operations and to allow continued support for the needs of its business following the clinical hold on atuzaginstat’s (COR388) Investigational New Drug application (IND 134303). Under the cost reduction program, Cortexyme stated that it is reducing headcount by approximately 53% through a workforce reduction.

Cortexyme Shareholders Who Have Lost Money On Their Investment

Cortexyme investors who have suffered financial losses are encouraged to complete Kehoe Law Firm’s Securities Class Action Questionnaire or contact Kehoe Law Firm, P.C., [email protected], to discuss potential legal claims. 

Kehoe Law Firm, P.C.